Lenz & Staehelin advised Hasten in this transaction.Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Marco Zingaro
…
This content is for Standard 1 Year members only. LoginJoin Now